Therapeutic implications of immunogenic cell death in human cancer - Archive ouverte HAL Access content directly
Journal Articles Frontiers in Immunology Year : 2014

Therapeutic implications of immunogenic cell death in human cancer

(1) , (1) , (2) , (1) , (2)
1
2

Abstract

Dendritic cells (DCs) are central to the adoptive immune response, and their function is regulated by diverse signals in a context-specific manner. Different DCs have been described in physiologic conditions, inflammation, and cancer, prompting a series of questions on how adoptive immune responses, or tolerance, develop against tumors. Increasing evidence suggests that tumor treatments induce a dramatic change on tumor-infiltrating lymphocytes and, in particular, on some DC subtypes. In this review, we summarize the latest evidence on the role of DCs in cancer and preliminary evidence on chemotherapy-associated antigens identified in human cancers.
Fichier principal
Vignette du fichier
fimmu-04-00503.pdf (674.56 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

pasteur-01148979 , version 1 (06-05-2015)

Identifiers

Cite

Fabio Palombo, Chiara Focaccetti, Vincenzo Barnaba, Fabio Palombo, Vincenzo Barnaba. Therapeutic implications of immunogenic cell death in human cancer. Frontiers in Immunology, 2014, pp.6. ⟨10.3389/fimmu.2013.00503⟩. ⟨pasteur-01148979⟩

Collections

RIIP RIIP_FCB
34 View
242 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More